RxDoctor Payments Data

Melissa Salter

Family · Lemoyne, PANPI 1811559610

Payments from drug & device makers

$1,822in general payments, 2019–2025

Across 89 payments — averaging $20.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$359
  • GSK$324
  • Lilly USA, LLC$237
  • Novo Nordisk$101
  • AstraZeneca$86
  • Exact Sciences$81
  • plus $634 from 23 others

What the payments were for

  • Food & beverage$1,822100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,822 in reported general payments places this provider in the 80th percentile of 4,717 family providers in Pennsylvania.

See all family providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$12,693
Medicare patients
93
Services billed
258

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban52$65,442
JardianceEmpagliflozin15$23,252
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$15,030
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate13$3,144
PradaxaDabigatran Etexilate Mesylate12$2,323
Ezetimibe33$1,922
Atorvastatin Calcium114$1,700
Levothyroxine Sodium122$1,326
Gabapentin80$1,213
Venlafaxine Hcl ErVenlafaxine Hcl30$1,185
Metoprolol Succinate45$1,163
Pantoprazole Sodium91$1,113
Bupropion XlBupropion Hcl22$1,012
Mirtazapine22$1,003
Albuterol Sulfate HfaAlbuterol Sulfate37$940

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$47$65,44252 claims
Boehringer IngelheimJardiance, Pradaxa$15$25,57527 claims
GSKTrelegy Ellipta$324$15,03017 claims
Almatica Pharma LLCSertraline Hcl$22$30740 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,717 family providers in Pennsylvania.

Other family in Lemoyne

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →